SCHEDULE 13G

Company

Ascendis Pharma A/S

Filed

August 31, 2015

Accession Number

0001193125-15-308190

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →